ASCO endorses SIO guideline for integrative Tx in breast cancer

August 4, 2018

(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treatment, according to a special article published online June 11 in the Journal of Clinical Oncology.

Gary H. Lyman, M.D., M.P.H., from the University of Washington in Seattle, and colleagues address the use of integrative therapies for the management of symptoms and side effects during and after breast cancer treatment. Interventions of interest included mind and body practices, natural products, and lifestyle modifications. The SIO systematic reviews focused on ; the guideline was reviewed by ASCO content experts for clinical accuracy and by ASCO methodologists for developmental rigor.

After determining that the SIO guideline recommendations were clear, thorough, and based on the most relevant scientific evidence, the ASCO Expert Panel endorsed the guideline with a few added points of discussion. Key recommendations include music , meditation, stress management, and yoga for reduction of anxiety/stress. For depression/mood disorders, meditation, relaxation, yoga, massage, and music therapy are recommended. To improve quality of life, meditation and yoga are recommended. For reducing chemotherapy-induced nausea and vomiting, acupressure and acupuncture are recommended. Because of a possibility of harm, acetyl-L-carnitine is not recommended to prevent chemotherapy-induced peripheral neuropathy.

"No strong evidence supports the use of ingested dietary supplements to manage related adverse effects," the authors write.

Several authors disclosed financial ties to the biopharmaceutical industry.

Explore further: ASCO endorses integrative oncology guidelines for breast cancer patients

More information: Abstract/Full Text

Related Stories

ASCO endorses integrative oncology guidelines for breast cancer patients

June 12, 2018
The first time Elizabeth Johnson told her oncologist she wanted to start folding integrative therapies into her breast cancer treatment regimen as a way to alleviate side effects, he told her "Sure, you can try, but it's ...

Growing body of evidence supports use of mind-body therapies in breast cancer treatment

April 24, 2017
In newly updated clinical guidelines from the Society for Integrative Oncology (SIO), researchers at Columbia University's Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center with an interdisciplinary ...

ASCO endorses ACS guideline for prostate CA survivor care

February 13, 2015
(HealthDay)—The American Society of Clinical Oncology (ASCO) has endorsed the American Cancer Society (ACS) Prostate Cancer Survivorship Care Guidelines, according to a report published online Feb. 9 in the Journal of Clinical ...

ASCO endorses guideline for radiation after prostatectomy

November 6, 2014
(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed a recent guideline for adjuvant and salvage radiotherapy after prostatectomy. The endorsement was published online Nov. 3 in the Journal of Clinical ...

Report card on complementary therapies for breast cancer

October 27, 2014
Over eighty percent of breast cancer patients in the United States use complementary therapies following a breast cancer diagnosis, but there has been little science-based guidance to inform clinicians and patients about ...

New guidelines for treating form of advanced breast cancer

September 2, 2014
(HealthDay)—A leading group of oncologists has released updated guidelines for the treatment of the major form of advanced breast cancer.

Recommended for you

Two ways cancer resists treatment are actually connected, with one activating the other

December 18, 2018
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...

HPV discovery raises hope for new cervical cancer treatments

December 18, 2018
Researchers at the University of Virginia School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.

Vaccine, checkpoint drugs combination shows promise for pancreatic cancers

December 18, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...

Researchers identify ways breast cancer avoids immune system detection

December 18, 2018
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team ...

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.